Cargando…
In silico repurposing of a Novobiocin derivative for activity against latency associated Mycobacterium tuberculosis drug target nicotinate-nucleotide adenylyl transferase (Rv2421c)
Nicotinamide-nucleotide adenylyl transferase (Rv2421c) was selected as a potential drug target, because it has been shown, in vitro, to be essential for Mycobacterium tuberculosis growth. It is conserved between mycobacterium species, is up-regulated during dormancy, has a known 3D crystal structure...
Autores principales: | Cloete, Ruben, Shahbaaz, Mohd, Grobbelaar, Melanie, Sampson, Samantha L., Christoffels, Alan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562812/ https://www.ncbi.nlm.nih.gov/pubmed/34727137 http://dx.doi.org/10.1371/journal.pone.0259348 |
Ejemplares similares
-
Repurposing Based Identification of Novel Inhibitors against MmpS5-MmpL5 Efflux Pump of Mycobacterium smegmatis: A Combined In Silico and In Vitro Study
por: Shahbaaz, Mohd, et al.
Publicado: (2022) -
New structural forms of a mycobacterial adenylyl cyclase Rv1625c
por: Barathy, Deivanayaga, et al.
Publicado: (2014) -
Designing novel possible kinase inhibitor derivatives as therapeutics against Mycobacterium tuberculosis: An in silico study
por: Shahbaaz, Mohd, et al.
Publicado: (2019) -
Molecular modelling and simulation studies of the Mycobacterium tuberculosis multidrug efflux pump protein Rv1258c
por: Cloete, Ruben, et al.
Publicado: (2018) -
Selection of a Microprocessor for the Successor of the ACC 2421
por: Heinze, W, et al.
Publicado: (1982)